Overview


According to FutureWise analysis the market for arachnoid cysts treatment is expected to register a CAGR of 5.10% from 2023-2031.

Arachnoid cysts are referred to as collections of cerebrospinal fluid (CSF) that form between the arachnoid and pia mater, two of the three layers of tissue that shroud the brain and spinal cord. Most arachnoid cysts are small and do not cause any symptoms. However, larger cysts can put pressure on the brain or spinal cord, causing a variety of symptoms, such as headaches, seizures, numbness, weakness, and pain. Treatment for arachnoid cysts depends on the size and area of the cyst, as well as the severity of the symptoms. If the cyst is small and not causing any symptoms, the doctor may recommend simply monitoring it. However, if the cyst is large or causing symptoms, the doctor may recommend surgery or shunting.

When it comes to treatment options, several surgical procedures have been developed to alleviate the effects of arachnoid cysts. One approach is installing a permanent drainage system, which involves the placement of a shunt or catheter to divert excess cerebrospinal fluid away from the cyst, thus relieving pressure. This method is specifically beneficial in cases where the cyst is causing significant discomfort or impairment. Fenestration is another surgical technique used to address arachnoid cysts. This procedure involves creating a small opening or "window" in the cyst's membrane, allowing the excess fluid to flow into the surrounding cerebrospinal fluid spaces and be absorbed by the body. Fenestration can be performed using traditional surgical techniques or through minimally invasive procedures. Endoscopic cyst fenestration is a less invasive option than traditional surgical methods. This procedure employs an endoscope, a thin, flexible tube with a camera affixed, inserted through a small incision. The endoscope allows surgeons to visualize and access the cyst, facilitating the creation of a fenestration. This minimally invasive approach typically leads to quicker recovery times and reduced post-operative discomfort.

FutureWise Market Research has published a report that provides an insightful analysis arachnoid cysts treatment market trends that are affecting the overall market growth. This report will provide a detailed analysis of market share, regional insights, and competitor analysis that includes stature of key manufacturers operational in this industry. According to the analysis conducted by FutureWise research analysts arachnoid cysts treatment market is estimated to register a considerable growth rate over the forecast period. This report lists the market segments and potential prospects available across this industry, in addition providing crucial information on the total valuation currently held by the industry. Moreover, this report will assist key management individuals in an organisation to enhance their decisions pertaining to business expansion as well as strategic changes for increasing customer base.

  • Spiegelberg GmbHCo., KG
  • Spophysa
  • Assculap Inc
  • DePuy Synthes
  • Medtronic
  • Tokibo Co., Ltd.
  • Boston Neurosciences
  • Koninkliijke Philips N.V.
  • General Electric
  • Hitachi medical Systems Euroope
  • Siemens healthcare
  • FUJIFILM
  • Johnson and Johnson
  • B.Braun Melsungen

(Note: The list of the major players will be updated with the latest market scenario and trends)

The increasing diagnosis of arachnoid cysts may be attributed to several key drivers. Firstly, heightened awareness among both healthcare professionals and the general population about the condition has led to more proactive screening and detection. Additionally, advancements in diagnostic technologies, such as improved imaging techniques and more accurate diagnostic tools, have enabled healthcare providers to identify arachnoid cysts with greater precision. Moreover, the aging population, which is more prone to neurological conditions, contributes to the rising incidence of arachnoid cyst diagnoses. As individuals age, they may undergo more comprehensive medical assessments, increasing the likelihood of detecting these cysts. Collectively, these factors synergistically drive the upward trend in arachnoid cyst diagnoses, underscoring the importance of continued advancements in awareness and diagnostic capabilities. Furthermore, the escalating preference for minimally invasive procedures is a pivotal driver in arachnoid cyst treatments. Both patients and healthcare providers are increasingly drawn to these less invasive techniques due to their potential for shorter recovery times, reduced post-operative pain, and lower risk of difficulties compared to traditional open surgeries. Endoscopic fenestration, in particular, stands out as a promising treatment option. As demand for procedures like endoscopic fenestration continues to rise, it is poised to play a pivotal role in shaping the landscape of arachnoid cyst treatments. Also, the remarkable progress in medical technology stands as a significant opportunity in the realm of arachnoid cyst treatments. Breakthroughs in medical imaging, such as high-resolution MRI and CT scans, offer unprecedented clarity in visualizing arachnoid cysts, enabling precise localization and characterization, further driving the market growth. However, the cost factor poses a significant restraint in the landscape of arachnoid cyst treatments. Certain treatment options, particularly surgical interventions or specialized therapies, may incur substantial expenses. This financial burden may impede access to these crucial treatments, particularly for patients in regions with constrained healthcare budgets or inadequate insurance coverage. For individuals without comprehensive insurance plans, the out-of-pocket expenses associated with arachnoid cyst treatments may be prohibitively high, potentially delaying or even preventing them from receiving necessary care. This financial barrier underscores the need for concerted efforts to address affordability concerns and ensure equitable access to effective arachnoid cyst treatments, regardless of socioeconomic status or geographical location.

By Type

  • Intracranial
  • Spinal
  • Permanent Drainage System Surgery
  • Endoscopic Cyst Fenestration

By Diagnosis

  • CT Scan
  • MRI Scan
  • Prenatal Ultrasound
  • Others

By Treatment

  • Permanent Drainage System Surgery
  • Fenestration
  • Endoscopic Cyst Fenestration

By Application

  • Hospitals
  • Clinics
  • Others

By Region

  • North America
  • Europe
  • Asia-Pacific
  • Latin America
  • Middle East and Africa

This market research report also emphasis on factors affecting the growth rate in various regions listed above. A deep-down analysis of region will also be provided in the final version of this market which is based on conclusion of primary interviews and secondary data point gathered during the process.

By region, the market is segmented into North America, Latin America, Europe, Asia-Pacific, and Middle East & Africa. North America registered highest share in the market in 2022. This is attributed to factors such as the growing prevalence of minimally invasive surgeries, the favorable reimbursement scenario, rising expenditure to develop healthcare infrastructure, growing awareness, rising prevalence of brain disorders, and increasing personal disposable income in Asia Pacific, which is likely to bolster the target market growth over the projection period. In addition, technological advancements, government support for healthcare facilities, the presence of key players, and a rise in research and development activities is further projected to accelerate the growth of the market over the forecast period in the region.

  • Tier 1 players- established companies in the market with a major market share
  • Tier 2 players
  • Emerging players which are growing rapidly
  • New Entrants
  • Growth prospects
  • SWOT analysis
  • Key trends
  • Key data-points affecting market growth
  • To provide with an exhaustive analysis on the Arachnoid Cysts Treatment Market By Type, By Diagnosis, By Treatment, By Application and By Region.
  • To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
  • To evaluate and forecast micro-markets and the overall market
  • To predict the market size, in key regions— North America, Europe, Asia Pacific, Latin America and Middle East and Africa.
  • To record and evaluate competitive landscape mapping- product launches, technological advancements, mergers and expansions
  • We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
  • The customization Mobility Care offered are free of charge with purchase of any license of the report
  • You can directly share your requirements/changes to the current table of content to:sales@futurewiseresearch.com

Table of Contents


  • 1.   Market Introduction
    •   1. Objectives of the Study
        2. Market Definition
        3. Market Scope
         3.1. Years Considered for the Study
         3.2. Market Covered
        4. Currency
        5. Limitations
        6. Stakeholders
  • 2.   Research Methodology
    •   1. Research Data
         1.1. Secondary Data
          1.1.1. Key Data from Secondary Sources
         1.2. Primary Data
          1.2.1. Key Data from Primary Sources
        2. Market Size Estimation
        3. Market Breakdown and Data Triangulation
        4. Assumptions for the Study
  • 3.   Executive Summary
    •   1. Market Outlook
        2. Segment Outlook
        3. Competitive Insights
  • 4.   Arachnoid Cysts Treatment Market Variables, Trends and Scope
    •   1. Market Lineage Outlook
        2. Penetration and Growth Prospect Mapping
        3. Industry Value Chain Analysis
        4. Cost Analysis Breakdown
        5. Technology Overview
        6. Regulatory Framework
         6.1. Reimbursement Framework
         6.2. Standards and Compliances

  • 5.   Market Overview
    •   1. Market Dynamics
         1.1. Market Driver Analysis
          1.1.1. Increasing focus of Arachnoid Cysts Treatment Market Companies on Brand Protection
          1.1.2. Untapped Opportunities in Emerging Regions
         1.2. Market Restraint Analysis
          1.2.1. High Cost Associated with Implementation of Predictive Analysis
         1.3. Industry Challenges
          1.3.1. Presence of Ambiguous Regulatory Framework
  • 6.   Arachnoid Cysts Treatment Market Analysis Tools
    •   1. Industry Analysis - Porter’s
         1.1. Supplier Power
         1.2. Buyer Power
         1.3. Substitution Threat
         1.4. Threat from New Entrants
         1.5. Competitive Rivalry
        2. Pestel Analysis
         2.1. Political Landscape
         2.2. Environmental Landscape
         2.3. Social Landscape
         2.4. Technology Landscape
         2.5. Legal Landscape
        3. Major Deals And Strategic Alliances Analysis
         3.1. Joint Ventures
         3.2. Mergers and Acquisitions
         3.3. Licensing and Partnership
         3.4. Technology Collaborations
         3.5. Strategic Divestments
        4. Market Entry Strategies
        5. Case Studies
  • 7.   Arachnoid Cysts Treatment Market, By Type Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Intracranial
        2. Spinal
        3. Permanent Drainage System Surgery
        4. Endoscopic Cyst Fenestration

  • 8.   Arachnoid Cysts Treatment Market, By Diagnosis Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. CT Scan
        2. MRI Scan
        3. Prenatal Ultrasound
        4. Others

  • 9.   Arachnoid Cysts Treatment Market, By Treatment Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Permanent Drainage System Surgery
        2. Fenestration
        3. Endoscopic Cyst Fenestration

  • 10.   Arachnoid Cysts Treatment Market, By Application Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Hospitals
        2. Clinics
        3. Others

  • 11.   North America Arachnoid Cysts Treatment Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. U.S.A
         2.2. Canada
         2.3. Mexico
        3. Market Size (USD Million) Forecast for North America 2023-2031

  • 12.   Latin America Arachnoid Cysts Treatment Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Brazil
         2.2. Venezuela
         2.3. Argentina
         2.4. Rest of Latin America
        3. Market Size (USD Million) Forecast for Latin America 2023-2031

  • 13.   Europe Arachnoid Cysts Treatment Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Germany
         2.2. U.K
         2.3. France
         2.4. Italy
         2.5. Spain
         2.6. Russia
         2.7. Poland
         2.8. Rest of Europe
        3. Market Size (USD Million) Forecast for Europe 2023-2031

  • 14.   Asia Pacific Arachnoid Cysts Treatment Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Japan
         2.2. China
         2.3. India
         2.4. Australia and New Zealand
         2.5. ASEAN
         2.6. Rest of Asia Pacific
        3. Market Size (USD Million) Forecast for Asia Pacific 2023-2031

  • 15.   Middle East and Africa Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. GCC
         2.2. Israel
         2.3. South Africa
         2.4. Rest of MEA
        3. Market Size (USD Million) Forecast for MEA 2023-2031

  • 16.   Market Share Analysis and Competitive Landscape
    •   1. Global Landscape - Key Players, Revenue and Presence
        2. Global Share Analysis - Key Players (Tier 1, Tier 2, Tier 3)
        3. Global Emerging Companies
        4. North America - Market Share Analysis and Key Regional Players
        5. Europe - Market Share Analysis and Key Regional Players
        6. Asia Pacific - Market Share Analysis and Key Regional Players
        7. Global Key Player - Growth Matrix
  • 17.   Company Profiles (Competition Dashboard, Competitors Deep Dive, Products Offered and Financial Layouts)
    •   1. Spiegelberg GmbHCo., KG
         1.1. Company Overview
         1.2. Product Portfolio
         1.3. SWOT Analysis
         1.4. Financial Overview
         1.5. Strategic Overview
        2. Spophysa
         2.1. Company Overview
         2.2. Product Portfolio
         2.3. SWOT Analysis
         2.4. Financial Overview
         2.5. Strategic Overview
        3. Assculap Inc
         3.1. Company Overview
         3.2. Product Portfolio
         3.3. SWOT Analysis
         3.4. Financial Overview
         3.5. Strategic Overview
        4. DePuy Synthes
         4.1. Company Overview
         4.2. Product Portfolio
         4.3. SWOT Analysis
         4.4. Financial Overview
         4.5. Strategic Overview
        5. Medtronic
         5.1. Company Overview
         5.2. Product Portfolio
         5.3. SWOT Analysis
         5.4. Financial Overview
         5.5. Strategic Overview
        6. Tokibo Co., Ltd.
         6.1. Company Overview
         6.2. Product Portfolio
         6.3. SWOT Analysis
         6.4. Financial Overview
         6.5. Strategic Overview
        7. Boston Neurosciences
         7.1. Company Overview
         7.2. Product Portfolio
         7.3. SWOT Analysis
         7.4. Financial Overview
         7.5. Strategic Overview
        8. Koninkliijke Philips N.V.
         8.1. Company Overview
         8.2. Product Portfolio
         8.3. SWOT Analysis
         8.4. Financial Overview
         8.5. Strategic Overview
        9. General Electric
         9.1. Company Overview
         9.2. Product Portfolio
         9.3. SWOT Analysis
         9.4. Financial Overview
         9.5. Strategic Overview
        10. Hitachi medical Systems Euroope
         10.1. Company Overview
         10.2. Product Portfolio
         10.3. SWOT Analysis
         10.4. Financial Overview
         10.5. Strategic Overview
        11. Siemens healthcare
         11.1. Company Overview
         11.2. Product Portfolio
         11.3. SWOT Analysis
         11.4. Financial Overview
         11.5. Strategic Overview
        12. FUJIFILM
         12.1. Company Overview
         12.2. Product Portfolio
         12.3. SWOT Analysis
         12.4. Financial Overview
         12.5. Strategic Overview
        13. Johnson & Johnson
         13.1. Company Overview
         13.2. Product Portfolio
         13.3. SWOT Analysis
         13.4. Financial Overview
         13.5. Strategic Overview
        14. B.Braun Melsungen
         14.1. Company Overview
         14.2. Product Portfolio
         14.3. SWOT Analysis
         14.4. Financial Overview
         14.5. Strategic Overview

  • 18.   Pre and Post COVID-19 Impact
    •   1. Positive influence on the healthcare industry
        2. The financial disruption of the manufacturing sector
        3. Impact of COVID-19 on emerging companies
        4. Significant mandates in the healthcare regulations initiated by administrations
        5. The overall economic slowdown of the developing and developed nations
  • 19.   FutureWise SME Key Takeaway Points for Client
Partner

Our Clients